Subscribe to RSS Feed
Medicines-Diabetes Treatment-InstituteOfEPM-Medice-Ipsen-EndoPharm-NovoNordisk-Ursapharm-Valenta-Shering-Plau-Rompharm-Pharmstandart-EGIS-Medisorb-Sandoz-Kamelia-Italfarmaco-Bristol-Myers Squibb-SUNpharma-UPSA-Adipharm-Biocodex-Dompe-Hyperion-Hexal-Avexima-НПЦРИЗ-Nanox-Фармстандарт-Лексредства ОАО
Ozempic® (Semavik) 0,25/0,5/1 mg/dose solution for subcutaneous administration 3 ml syringe pen 1 pc.
Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.
Medicines-Diabetes Treatment-InstituteOfEPM-Medice-Ipsen-EndoPharm-NovoNordisk-Ursapharm-Valenta-Shering-Plau-Rompharm-Pharmstandart-EGIS-Medisorb-Sandoz-Kamelia-Italfarmaco-Bristol-Myers Squibb-SUNpharma-UPSA-Adipharm-Biocodex-Dompe-Hyperion-Hexal-Avexima-НПЦРИЗ-Nanox-Фармстандарт-Лексредства ОАО
Currently Shopping by
- The purpose of the medication: Remove This Item Diabetes Treatment
-
Manufacturer:
InstituteOfEPM
Medice
Ipsen
EndoPharm
NovoNordisk
Ursapharm
Valenta
Shering-Plau
Rompharm
Pharmstandart
EGIS
Medisorb
Sandoz
Kamelia
Italfarmaco
Bristol-Myers Squibb
SUNpharma
UPSA
Adipharm
Biocodex
Dompe
Hyperion
Hexal
Avexima
НПЦРИЗ
Nanox
OTCPharm JSC
- The purpose of the medication
- Manufacturer
